BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8117522)

  • 21. [Regression of left ventricular hypertrophy in hypertensive heart disease].
    Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
    Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
    Motz W; Strauer BE
    Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypertension and heart].
    Hennersdorf MG; Strauer BE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():27-30. PubMed ID: 16802514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure.
    Afshinnia F; Spitalewitz S; Chou SY; Gunsburg DZ; Chadow HL
    Am J Kidney Dis; 2007 Feb; 49(2):227-36. PubMed ID: 17261425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prognosis of the disease course in patients with hypertension and coronary failure].
    Iureneev AP; Gerashchenko IuS; Dubov PB
    Ter Arkh; 1994; 66(4):9-11. PubMed ID: 8016741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From hypertension to heart failure: what have we learned?
    Wilson PW
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V1-10. PubMed ID: 10526697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertensive heart disease. How does blood pressure affect left ventricular mass?
    Prisant LM; Houghton JL; Bottini PB; Carr AA
    Postgrad Med; 1994 May; 95(6):59-62, 66-76. PubMed ID: 8170874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P
    Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and the heart.
    Mancia G; Scopelliti F; Grassi G
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):198-202. PubMed ID: 16959750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arterial stiffness in arterial hypertension. A new risk factor for left ventricular hypertrophy and cardiac insufficiency?].
    Baulmann J; Homsi R; Un S; Vetter H; Düsing R; Mengden T
    Dtsch Med Wochenschr; 2004 Feb; 129(9):447-52. PubMed ID: 14970918
    [No Abstract]   [Full Text] [Related]  

  • 39. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.